Healthcare Industry News: hemodialysis
News Release - April 25, 2011
Amerinet Signs New Agreement with Teleflex Incorporated for Arrow Peripherally Inserted Central CathetersLIMERICK, Pa.--(Healthcare Sales & Marketing Network)-- Teleflex Incorporated (NYSE:TFX ), a leading global provider of medical devices for critical care and surgery, has announced a new three-year agreement with Amerinet, Inc., a national healthcare group purchasing organization. Amerinet selected Arrow Peripherally Inserted Central Catheters (PICCs) as part of a multi source agreement. The new agreement begins May 1, 2011 and extends through April 30, 2014.
The Arrow PICC product line includes the recently introduced Arrow EVOLUTION™ PICC with Chlorag+ard™ antimicrobial technology, the first Chlorhexidine-treated peripherally inserted central catheter with both intraluminal and extraluminal protection. Chlorag+ard technology provides broad spectrum antimicrobial protection against bacterial and fungal colonization.
The broad range of Arrow vascular access products includes central venous access catheters, peripherally inserted central catheters, multi access catheters and acute hemodialysis catheters many of which are now available in ErgoPack Maximal Barrier Precautions Trays, a system designed to support compliance with best practice and guidelines for catheter insertion.
Teleflex also recently expanded its vascular access product offerings with the acquisition of the VasoNova VPS, vascular positioning system, a central venous catheter tip navigation system.
As a leading national healthcare group purchasing organization, Amerinet collaborates with acute and alternate care providers to create and deliver unique solutions through performance improvement resources, guidance and ongoing support. With better product standardization and utilization, new financial tools beyond contracting and alliances that help lower costs, raise revenue and champion quality, Amerinet enriches healthcare delivery for its members and the communities they serve. To learn more about how Amerinet can help you successfully navigate the future of healthcare reform, visit www.amerinet-gpo.com.
About Teleflex Incorporated
Teleflex is a leading global provider of specialty medical devices for a range of procedures in critical care and surgery. Our mission is to provide solutions that enable healthcare providers to improve outcomes and enhance patient and provider safety. Headquartered in Limerick, PA, Teleflex employs approximately 12,000 people worldwide and serves healthcare providers in more than 130 countries. The company also has niche businesses which produce specialty engineered products for the aerospace market. For additional information about Teleflex please refer to www.teleflex.com.
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management's current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.